Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Early Detection
100%
PARP Inhibitor (PARPi)
100%
Esophageal Adenocarcinoma
100%
Fluorescence Endoscopy
100%
Esophageal Dysplasia
100%
PARPi-FL
100%
Barrett's Esophagus
40%
Interleukin-1β
30%
Dysplastic Lesions
30%
Immunohistochemistry
20%
Stomach
20%
Confocal Microscopy
20%
Organoids
20%
Incubation
10%
Transgenic Mice
10%
Clinical Translation
10%
Common Cancers
10%
Imaging Technology
10%
Surveillance Protocol
10%
Esophageal Cancer
10%
Disease Stage
10%
Excised Tissue
10%
Precancerous Lesions
10%
White Light Endoscopy
10%
Intravenous Injection
10%
Epithelial Cells
10%
Untargeted
10%
Wild Mice
10%
Mouse Tissue
10%
Tumor-specific
10%
Topical Application
10%
Nonmalignant
10%
Phase II Clinical Trial
10%
Molecular Probe
10%
Patient-derived Organoids
10%
Improved Detection
10%
Dysplasia
10%
Endoscopic Screening
10%
Endoscopic Imaging
10%
Inhuman
10%
Human Biospecimens
10%
Oral Cancer Screening
10%
Seattle Protocol
10%
Confocal Immunohistochemistry
10%
Medicine and Dentistry
Endoscopy
100%
Adenocarcinoma
100%
Dysplasia
100%
Nicotinamide Adenine Dinucleotide Adenosine Diphosphate Ribosyltransferase 1
100%
Barrett Esophagus
66%
Immunohistochemistry
50%
Organoid
50%
Esophageal Adenocarcinoma
50%
Confocal Microscopy
33%
Clinical Trial
16%
Malignant Neoplasm
16%
Transgenic Mouse
16%
Cancer
16%
Cancer Diagnosis
16%
Biopsy Technique
16%
Esophageal Cancer
16%
White Light Endoscopy
16%
Oral Cancer
16%
Epithelial Cell
16%
Incubation
16%
Topical Drug Administration
16%
Specific Tumor
16%
Diseases
16%
Intravenous Injection
16%